Info
Insider Ownership

Insider Trading & Ownership of Mark Rothera

Location: Cambridge, MA
Summary: The estimated net worth of Mark Rothera is at least $49.3K dollars as of March 13, 2024. Mark Rothera is the President and CEO, Director of Viracta Therapeutics, Inc. and owns shares of Viracta Therapeutics, Inc. (VIRX) stock worth about $49.3K.
Signature: Daniel Chevallard, as Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Mark Rothera files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Mark Rothera

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
VIRX	Viracta Therapeutics, Inc.	President and CEO, Director	$49.3K			Mar 12, 2024

Insider Transactions Reported by Mark Rothera:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.